Research Article

Characteristics and Surgical Results of Patients with Hypertrophic Obstructive Cardiomyopathy without Intrinsic Mitral Valve Diseases Undergoing Mitral Subvalvular Procedures during Myectomy

Table 1

Baseline and surgical characteristics.

VariablesCombined group (n = 50)Alone group (n = 131) value

Demographics
 Age (years)52.9 ± 11.256.8 ± 11.80.045
 Gender (male)31 (62.0%)66 (50.4%)0.161
 Recent smoking17 (34.0%)29 (22.1%)0.101
Concomitant diseases
 Diabetes mellitus5 (10.0%)11 (8.4%)0.772
 Hypertension20 (40.0)51 (38.9%)0.895
 Cerebrovascular disease3 (6.0%)8 (6.1%)>0.999
 Family history of HCM7 (14.0%)8 (6.1%)0.127
 Family history of sudden death4 (8.0%)2 (1.5%)0.049
Preoperative cardiac status
 NYHA functional class0.034
 II11 (22.0%)13 (10.0%)
 III36 (72.0%)97 (74.0%)
 IV3 (6.0%)21 (16.0%)
 Atrial fibrillation6 (12.0%)12 (9.2%)0.584
 Right bundle branch block1 (2.0%)3 (2.3%)>0.999
 MV subvalvular anomalies50 (100%)0
 False cords13 (26.0%)
 Retracted secondary chordae34 (68.0%)
 PM abnormalities17 (34.0%)
Echocardiographic data (TTE)
 Maximum gradients (mmHg)96.5 ± 17.892.2 ± 20.50.193
 Septal thickness (mm)16.4 ± 2.318.5 ± 3.2<0.001
 SAM31 (100%)180 (100%)1.000
 MR3.0 (2.0–3.0)3.0 (2.0–3.0)0.472
 LVEF (%)67.5 ± 4.866.6 ± 4.20.217
 LVEDD (mm)44.7 ± 4.644.6 ± 4.40.893
Procedures
 Myectomy50 (100%)131 (100%)1.000
 ACC time (min)38.1 ± 7.335.8 ± 7.50.065
 Myectomy plus subvalvular procedures50 (100%)0
 False cords cutting13 (26.0%)
 Retracted secondary chordae cutting34 (68.0%)
 PM release and/or resection17 (34.0%)

Values are expressed as n (percent), mean ± standard deviation or median and interquartile range. HCM, hypertrophic cardiomyopathy; NYHA, New York Heart Association (classification); LVOT, left ventricular outflow tract; MV, mitral valve; PM, papillary muscle; TTE, transthoracic echocardiography; MR, mitral regurgitation; SAM, systolic anterior motion; LVEF, left ventricular ejection fraction; LVEDD, left ventricular endo-diastolic diameter; ACC, aortic cross-clamping.